Skip to main content
. 2014 Sep 4;2014(9):CD006424. doi: 10.1002/14651858.CD006424.pub3

Middelkoop 2001.

Methods Parallel randomised controlled clinical trial (RCT) (for first 6 months)
Randomisation ratio: 53 intervention:60 control
Superiority design
Participants Inclusion criteria:
  • South Asian origin

  • Type 2 DM

  • No co‐morbidity interfering with interpretation of metabolic control (i.e. recent miocardial infarction or dementia)

  • Visited attending clinic during first half of the year 1998


Exclusion criteria: not stated
Diagnostic criteria: not stated
Interventions Number of study centres: 3 general practices and 1 outpatient clinic
Treatment before study: not stated
Intervention: attending to intensive guidance clinics (approximately 4‐7 visits for the first 3 months, with less frequent subsequent visits) provided by trained nurse and dietician
Control: wait‐listed group that joined the intervention group after 6 months
Provider: specialist nurse and dietician trained in South Asian culture
Outcomes Outcomes reported in abstract of publication:
Primary outcome(s): HbA1c
Secondary outcome(s): not assessed for RCT component of the intervention
Study details Run‐in period: not stated
Study terminated before regular end: no
Publication details Language of publication: English
Funding: not stated
Publication status: peer‐reviewed journal
Stated aim of study Quote from publication: "To assess if culturally‐specific diabetes intervention led to a decrease HbA1c level, improvement in lipid profile, or a decrease in BMI"
Notes
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) High risk Quote from publication: "Patients were randomised based on their date of birth: odd numbers (intervention patients)"
Allocation concealment (selection bias) Unclear risk Comment: not mentioned
Blinding of participants and personnel (performance bias) 
 Objective outcomes Unclear risk Comment: not clear whether participants would have been aware of whether they were in the control group
Blinding of participants and personnel (performance bias) 
 Subjective outcomes Unclear risk Comment: no subjective outcomes
Blinding of outcome assessment (detection bias) 
 Lab tests: Lipids, HBA1C Low risk Comment: does not mention whether laboratory technicians blinded but unlikely to have affected HbA1c
Blinding of outcome assessment (detection bias) 
 Subjective outcomes Unclear risk Comment: no subjective outcomes
Incomplete outcome data (attrition bias) 
 Objective outcomes Unclear risk Comment: 28/60 of control group lost to follow‐up as changed GP, does not provide further details of other participants lost to follow‐up
Incomplete outcome data (attrition bias) 
 Subjective outcomes Unclear risk Comment: no subjective outcomes
Selective reporting (reporting bias) Unclear risk Comment: HbA1c was only outcome in RCT reported on but protocol not seen (e.g. may have specified that investigators would look at BMI at 6 months)
Other bias Unclear risk Comment: none